טוען...
PROSTATE CANCER PREVENTION TRIAL RISK CALCULATOR 2.0 FOR THE PREDICTION OF LOW- VERSUS HIGH-GRADE PROSTATE CANCER
OBJECTIVES: To modify the Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) to predict low- versus high-grade (Gleason grade ≥ 7) prostate cancer and incorporate percent free PSA. METHODS: Data from 6664 PCPT placebo arm biopsies [5826 individuals] where prostate-specific antigen (PSA) and d...
שמור ב:
| Main Authors: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4035700/ https://ncbi.nlm.nih.gov/pubmed/24862395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2014.02.035 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|